HUP0103986A2 - New piperidinyl compound having carboxylic acid structures, process for their preparation and pharmaceutical compositions containing them - Google Patents

New piperidinyl compound having carboxylic acid structures, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HUP0103986A2
HUP0103986A2 HU0103986A HUP0103986A HUP0103986A2 HU P0103986 A2 HUP0103986 A2 HU P0103986A2 HU 0103986 A HU0103986 A HU 0103986A HU P0103986 A HUP0103986 A HU P0103986A HU P0103986 A2 HUP0103986 A2 HU P0103986A2
Authority
HU
Hungary
Prior art keywords
group
disorders
alkyl
formula
preparation
Prior art date
Application number
HU0103986A
Other languages
Hungarian (hu)
Inventor
Tibor Ács
Csongor Éva Ágainé
Béla Kiss
István Gyertyán
István Laszlovszky
dr. Szalai Gizella Bartáné
Krisztina Gál
Ildikó Magdó
Gábor Tárkányi
György Domány
Original Assignee
Richter Gedeon Vegyészeti Gyár Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyészeti Gyár Rt. filed Critical Richter Gedeon Vegyészeti Gyár Rt.
Priority to HU0103986A priority Critical patent/HUP0103986A2/en
Publication of HU0103986D0 publication Critical patent/HU0103986D0/en
Priority to PCT/HU2002/000094 priority patent/WO2003028725A1/en
Publication of HUP0103986A2 publication Critical patent/HUP0103986A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Abstract

A jelen találmány tárgya új D3 dopamin receptor altípusra nézveszelektív (I) általános képletű vegyületek mely képletben R1 és R2jelentése egymástól függetlenül hidrogénatom, halogénatom, 1-6szénatomos alkilcsoport, 1-6 szénatomos alkoxicsoport, cianocsoport,hidroxicsoport, trifluormetil-csoport, (1-6 szénatomos alkil)-szulfoniloxi-csoport, trifluormetil-szulfoniloxicsoport, (adottesetben helyettesített 1-6 szénatomos alkanoil)-oxicsoport, amino-csoport, amino(1-6 szénatomos alkil)-csoport, karboxicsoport,aminokarbonil-csoport, N-hidroxi-karbamimidoilcsoport, karbamimidoil-csoport, hidroxi-karbamoil-csoport, tiokarbamoil-csoport, szulfamoil-csoport, vagy monociklusos vagy biciklusos heterociklikus-csoport; Yjelentése oxigénatom vagy egy -NH- képletű csoport vagy egy -CH2-képletű csoport vagy egy -OCH2- képletű csoport; Q jelentése adottesetben helyettesített 1-6 szénatomos alkilcsoport, arilcsoport,heteroaril-csoport, heteroaralkil-csoport vagy heteroaralkenil-csoport, és/vagy geometriai izomerjeik és/vagy sztereoizomerjeikés/vagy diasztereomerjeik és/vagy sóik és/vagy hidrátjaik és/vagyszolvátjaik, valamint ezek előállítási eljárásai, ezeket tartalmazógyógyászati készítmények és alkalmazásuk pszichózisok (példáulszkizofrénia, szkizo-affektív rendellenességek, stb.), drogfüggőség(például alkohol, kokain és nikotin, opiumkészítmények, stb.), aszkizofréniát kísérő kognitív zavarok, enyhétől mérsékeltig terjedőkognitív károsodások, emlékezetkiesés, evési rendellenességek (példáulbulimia nervosa, stb.), figyelemhiányos betegségek, gyermekkorihiperaktivitás, pszichotikus depresszió, mánia, paranoiás éstéveszmékkel járó betegségek, mozgászavarokkal társult betegségek(például Parkinson-kór, neuroleptikumok hatására létrejövő Parkinson-kór, tardív diszkinézia, szorongás, szexuális zavarok, alvászavar,hányás, agresszió, autizmus, fájdalom, szemészeti betegségek (példáulglaukóma, stb.) kezelésére és/vagy megelőzésére. ÓThe subject of the present invention is compounds of general formula (I) selective for the new D3 dopamine receptor subtype, in which R1 and R2 are independently hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 alkoxy group, cyano group, hydroxy group, trifluoromethyl group, (1-6 (C 1 -C 6 alkyl)sulfonyloxy group, trifluoromethylsulfonyloxy group, (substituted C 1 -C 6 alkanoyl)oxy group, amino group, amino (C 1 -C 6 alkyl) group, carboxy group, aminocarbonyl group, N-hydroxycarbamimidoyl group , a carbamimidoyl group, a hydroxycarbamoyl group, a thiocarbamoyl group, a sulfamoyl group, or a monocyclic or bicyclic heterocyclic group; Y is an oxygen atom or a group of the formula -NH- or a group of the formula -CH2 or a group of the formula -OCH2-; Q is an optionally substituted C1-C6 alkyl group, aryl group, heteroaryl group, heteroaralkyl group or heteroaralkenyl group, and/or their geometric isomers and/or stereoisomers and/or diastereomers and/or their salts and/or hydrates and/or solvates, and these production processes, medicinal preparations containing them and their use psychoses (e.g. schizophrenia, schizo-affective disorders, etc.), drug addiction (e.g. alcohol, cocaine and nicotine, opium preparations, etc.), cognitive disorders accompanying schizophrenia, mild to moderate cognitive impairments, memory loss, eating disorders (e.g. bulimia nervosa, etc.), attention deficit disorders, childhood hyperactivity, psychotic depression, mania, paranoid and delusional disorders, disorders associated with movement disorders (e.g. Parkinson's disease, neuroleptic-induced Parkinson's disease, tardive dyskinesia, anxiety, sexual disorders, sleep disorders, vomiting , aggression, autism, pain, eye diseases (for example, glaucoma, etc.) for treatment and/or prevention. HE

HU0103986A 2001-09-28 2001-09-28 New piperidinyl compound having carboxylic acid structures, process for their preparation and pharmaceutical compositions containing them HUP0103986A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0103986A HUP0103986A2 (en) 2001-09-28 2001-09-28 New piperidinyl compound having carboxylic acid structures, process for their preparation and pharmaceutical compositions containing them
PCT/HU2002/000094 WO2003028725A1 (en) 2001-09-28 2002-09-25 4-(1-piperidiny)-butylcarboxamide as d3 dopamine receptor subtype selective ligands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0103986A HUP0103986A2 (en) 2001-09-28 2001-09-28 New piperidinyl compound having carboxylic acid structures, process for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
HU0103986D0 HU0103986D0 (en) 2001-11-28
HUP0103986A2 true HUP0103986A2 (en) 2003-06-28

Family

ID=89979730

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103986A HUP0103986A2 (en) 2001-09-28 2001-09-28 New piperidinyl compound having carboxylic acid structures, process for their preparation and pharmaceutical compositions containing them

Country Status (2)

Country Link
HU (1) HUP0103986A2 (en)
WO (1) WO2003028725A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10359528A1 (en) 2003-12-18 2005-07-28 Schwarz Pharma Ag (S) -2-N-propylamino-5-hydroxytetralin as a D3 agonist therapeutic
EP1778658A2 (en) * 2004-07-20 2007-05-02 Siena Biotech S.p.A. Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
AU2006278396A1 (en) 2005-08-04 2007-02-15 Sirtris Pharmaceuticals, Inc. Benzimidazole derivatives as sirtuin modulators
WO2007093540A1 (en) * 2006-02-17 2007-08-23 F. Hoffmann-La Roche Ag Benzoyl-piperidine derivatives as 5ht2/d3 modulators
RU2009116509A (en) 2006-10-31 2010-12-10 Ф. Хоффманн-Ля Рош Аг (Ch) ETHERAL DERIVATIVES AS DUAL 5-NT2A AND D3 RECEPTOR MODULATORS
CL2008000119A1 (en) 2007-01-16 2008-05-16 Wyeth Corp COMPOUNDS DERIVED FROM PIRAZOL, ANTAGONISTS OF THE NICOTINIC ACETILCOLINE RECEIVER; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS SENILE DEMENTIA, ALZHEIMER AND SCHIZOPHRENIA.
TW200918542A (en) 2007-06-20 2009-05-01 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
MX2010001195A (en) * 2007-08-09 2010-03-01 Hoffmann La Roche Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors.
KR20110049866A (en) * 2008-09-01 2011-05-12 뉴로서치 에이/에스 Piperidine-4-acetamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US10787423B2 (en) * 2015-09-14 2020-09-29 The National Institute For Biotechnolgy In The Negev Ltd. Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction
KR101784964B1 (en) * 2016-05-04 2017-10-12 전남대학교산학협력단 Novel carboxamide derivates salt and use of the same
SG11201908351TA (en) * 2017-03-10 2019-10-30 Edmond J Lavoie Indole derivatives as efflux pump inhibitors
CN110041318B (en) * 2018-01-17 2022-07-29 中国科学院上海药物研究所 Dopamine D5 receptor agonist and preparation and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767131A (en) * 1993-04-05 1998-06-16 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
US5763609A (en) * 1996-03-21 1998-06-09 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands
CA2251625A1 (en) * 1996-04-24 1997-10-30 Yumiko Shibouta Fused imidazopyridine derivatives as antihyperlipidemic agents
DE19728996A1 (en) * 1997-07-07 1999-01-14 Basf Ag Triazole compounds and their use
WO1999021848A2 (en) * 1997-10-27 1999-05-06 Neurogen Corporation Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
US20040077654A1 (en) * 2001-01-15 2004-04-22 Bouillot Anne Marie Jeanne Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression

Also Published As

Publication number Publication date
HU0103986D0 (en) 2001-11-28
WO2003028725A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
JP4592077B2 (en) 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1 (NK-1) antagonists for the treatment of vomiting, depression, anxiety and cough
JP5281395B2 (en) Cyclohexanesulfonyl derivatives as GLYT1 inhibitors for the treatment of schizophrenia
JP6325449B2 (en) Cyclopropanamine compounds and uses thereof
HUP0103986A2 (en) New piperidinyl compound having carboxylic acid structures, process for their preparation and pharmaceutical compositions containing them
KR101721025B1 (en) Tetrahydrobenzothiophene compound
TW200505907A (en) Piperidine-benzenesulfonamide derivatives
TW201245159A (en) Aminodihydrothiazine derivatives
PT1682503E (en) Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
JP5947465B2 (en) Benzimidazoles as CNS activators
CN105085482B (en) Substituted diethylenediamine compound and its application method and purposes
ES2768823T3 (en) 2,3,4,5-Tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrole-5-amine derivatives useful as beta-secretase inhibitors
CN103443074A (en) Heterocyclic amine derivatives
NO330496B1 (en) Use of proline derivatives, pharmaceutical composition and proline derivatives
MX2012013637A (en) Anellated pyridine compounds as dual modulators of the 5-ht2a and d3 receptors.
HUP0401201A2 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
TW200911808A (en) Novel compounds
HUP0301272A2 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists, process for their preparation and their use for preparation of pharmaceutical compositions
US20160137643A1 (en) 1,7-naphthyridine derivatives
CA3157798A1 (en) 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity
CN100509782C (en) NK* antagonists
JP2019524818A (en) Sulfonylpyridyl TRP inhibitor
TW200700390A (en) Metabolites for nk-1 antagonists for emesis
WO2008077810A3 (en) Spiro-piperidine derivatives
TW200300088A (en) Piperazine derivatives having ssti antagonistic activity
MX2009005544A (en) Indoles.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees